(firstQuint)GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms.

 This is a prospective, non-randomized study designed to assess the feasibility of the TAMBE Device in the treatment of patients with aortic aneurysms involving the visceral branch vessels.

 A maximum of 10 Subjects will be treated under this Protocol.

 This clinical study will include up to six sites in the US.

 Each enrolled subject will undergo periodic follow-up evaluations involving physical exams, contrast-enhanced computed tomography (CT) of chest, abdomen and pelvis, creatinine measurement, abdominal ultrasound (optional) at specific, protocol-defined intervals for a period of five years following the GORE(R) EXCLUDER(R) Thoracoabdominal Branch Endoprosthesis impant.

.

 GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms@highlight

This study will assess the initial feasibility of the GORE(R) EXCLUDER(R) Thoracoabdominal Branch Endoprosthesis (TAMBE Device) in the treatment of Aortic Aneurysms Involving the Visceral Branch Vessels.

